Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

GABA and Dopamine Release from Different Brain Regions in Mice with Chronic Exposure to Organophosphate Methamidophos.

Noriega-Ortega BR, Armienta-Aldana E, Cervantes-Pompa JÁ, Armienta-Aldana E, Hernández-Ruíz E, Chaparro-Huerta V, Bravo-Cuellar A, Beas-Zárate C.

J Toxicol Pathol. 2011 Sep;24(3):163-8. doi: 10.1293/tox.24.163. Epub 2011 Oct 12.

2.

Methamidophos: an anticholinesterase without significant effects on postsynaptic receptors or transmitter release.

Camara AL, Braga MF, Rocha ES, Santos MD, Cortes WS, Cintra WM, Aracava Y, Maelicke A, Albuguergue EX.

Neurotoxicology. 1997;18(2):589-602.

PMID:
9291508
3.

Exposure to methamidophos at adulthood adversely affects serotonergic biomarkers in the mouse brain.

Lima CS, Nunes-Freitas AL, Ribeiro-Carvalho A, Filgueiras CC, Manhães AC, Meyer A, Abreu-Villaça Y.

Neurotoxicology. 2011 Dec;32(6):718-24. doi: 10.1016/j.neuro.2011.08.002. Epub 2011 Aug 19.

5.
6.

Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.

Hoffmann IS, Talmaciu RK, Ferro CP, Cubeddu LX.

J Pharmacol Exp Ther. 1988 Jun;245(3):761-72.

PMID:
3385641
7.

Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.

Schoffelmeer AN, Wardeh G, Vanderschuren LJ.

Synapse. 2001 Nov;42(2):87-94.

PMID:
11574945
8.
9.

GABA(B) modulation of dopamine release in the nucleus accumbens core.

Pitman KA, Puil E, Borgland SL.

Eur J Neurosci. 2014 Nov;40(10):3472-80. doi: 10.1111/ejn.12733. Epub 2014 Sep 17.

PMID:
25229321
10.
12.

Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex.

Tanahashi S, Ueda Y, Nakajima A, Yamamura S, Nagase H, Okada M.

Neuropharmacology. 2012 Apr;62(5-6):2057-67. doi: 10.1016/j.neuropharm.2012.01.005. Epub 2012 Jan 17.

PMID:
22266218
13.
14.

Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration.

Jacobs I, Anderson DJ, Surowy CS, Puttfarcken PS.

Neuropharmacology. 2002 Oct;43(5):847-56.

PMID:
12384170
15.

Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro.

Jackisch R, Huang HY, Reimann W, Limberger N.

J Pharmacol Exp Ther. 1993 Feb;264(2):889-98.

PMID:
8094757
16.

Attenuation of γ-aminobutyric acid (GABA) transaminase activity contributes to GABA increase in the cerebral cortex of mice exposed to β-cypermethrin.

Han Y, Cao D, Li X, Zhang R, Yu F, Ren Y, An L.

Hum Exp Toxicol. 2014 Mar;33(3):317-24. doi: 10.1177/0960327113497770. Epub 2013 Nov 12.

PMID:
24220872
17.

Chronic noise stress-induced alterations of glutamate and gamma-aminobutyric acid and their metabolism in the rat brain.

Kazi AI, Oommen A.

Noise Health. 2014 Nov-Dec;16(73):343-9. doi: 10.4103/1463-1741.144394.

18.

Differential effects of triethyllead on synaptosomal [3H]dopamine vs. [3H]acetylcholine and [3H]gamma-aminobutyric acid release.

Minnema DJ, Cooper GP, Schamer MM.

Neurotoxicol Teratol. 1991 May-Jun;13(3):257-65.

PMID:
1653396
19.

Absence of long-term behavioral effects after sub-chronic administration of low doses of methamidophos in male and female rats.

Temerowski M, van der Staay FJ.

Neurotoxicol Teratol. 2005 Mar-Apr;27(2):279-97. Epub 2005 Jan 15.

PMID:
15734279
20.

Inhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw.

Chen YI, Ren J, Wang FN, Xu H, Mandeville JB, Kim Y, Rosen BR, Jenkins BG, Hui KK, Kwong KK.

Neurosci Lett. 2008 Feb 6;431(3):231-5. doi: 10.1016/j.neulet.2007.11.063. Epub 2007 Dec 14.

Supplemental Content

Support Center